Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)
National Institutes of Health Nationwide (Federal)
Tell us about your organization and we'll show you whether this grant fits, and why.
Free to start. No credit card required.
Deadline
November 18, 2027
Region
Nationwide (Federal)
Funder type
Federal Government
For
Nonprofits & businesses
Sectors
Health & Human Services
About this program
Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed) — U.S. federal funding opportunity (RFA-DA-26-034) from National Institutes of Health. See grants.gov for full eligibility and details.
Is this grant worth your time?
Create a free account and Happy Grants scores this program, and 2,300+ others, against your organization’s profile in about a minute, with the reasons explained.
See your match score, freeSimilar grants
- Lasker Clinical Research Scholar's Program (Si2/R00 Clinical Trial Optional)National Institutes of Health Jul 7, 2028
- Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)National Institutes of Health Jan 7, 2028
- Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)National Institutes of Health Nov 18, 2026
- Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)National Institutes of Health Nov 18, 2026
- Short Courses on Innovative Methodologies and Approaches in the Behavioral and Social Sciences (R25 Clinical Trials Not Allowed)National Institutes of Health Apr 9, 2027
- Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32)National Institutes of Health May 4, 2028